Publications by authors named "Mark Leekoff"

Claim this Profile
S
Switching to ublituximab from prior anti-CD20 monoclonal antibody therapy: a case report series.
Regina Berkovich, Jonathan Calkwood, Heidi Crayton, April Erwin, Simon Faissner, Mark Leekoff

Front Immunol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Switching to ublituximab from prior anti-CD20 monoclonal antibody therapy: a case report series.
Regina Berkovich, Jonathan Calkwood, Heidi Crayton, April Erwin, Simon Faissner, Mark Leekoff

Front Immunol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Efficacy of COVID-19 Pre-Exposure Prophylaxis with Tixagevimab/Cilgavimab in People with Multiple Sclerosis.
Luke B Elias, Aliya Jaber, Margarita Manzano, Mark Leekoff, Andrew Sylvester

Vaccines (Basel)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of comorbid post traumatic stress disorder on multiple sclerosis in military veterans: A population-based cohort study.
Mark Leekoff, William Culpepper, Shan Jin, Terry Lee-Wilk, Mitchell Wallin

Mult Scler· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Reasoning: An unusual cause of adult cryptogenic ischemic stroke.
Mark L Leekoff, Julia E Masur, Allen P Burke, Jeremy S Pollock, Matthew N Peters

Neurology· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resident comfort level after receiving child abuse training: a survey of pediatric chief residents.
Jasmeen S Dara, Elon Y Kotlar, Mark L Leekoff, Xuan G Tran, Maria D McColgan

Child Abuse Negl· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis